SCHEMBL30225753

SCHEMBL30225753

Nc1ccnc2c1ncn2[C@@H]1O[C@H](CSCC[C@H](N)C(=O)O)[C@@H](O)[C@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNMT1 P26358 9/20 1.00
▸ DNMT3B Q9UBC3 8/20 1.00
▸ DOT1L Q8TEK3 9/20 0.75
▸ CARM1 Q86X55 2/20 0.75
▸ EHMT2 Q96KQ7 2/20 0.75
▸ PRMT1 Q99873 2/20 0.75
▸ TRDMT1 O14717 1/20 0.75
▸ PRMT5 O14744 1/20 0.75
▸ SUV39H1 O43463 1/20 0.75
▸ PRMT3 O60678 1/20 0.75
▸ INMT O95050 1/20 0.75
▸ NSD2 O96028 1/20 0.75
▸ PNMT P11086 1/20 0.75
▸ NNMT P40261 1/20 0.75
▸ HNMT P50135 1/20 0.75
▸ WDR5 P61964 1/20 0.75
▸ KMT2A Q03164 1/20 0.75
▸ SETDB1 Q15047 1/20 0.75
▸ RBBP5 Q15291 1/20 0.75
▸ EZH2 Q15910 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14174720 0.88 DNMT1 (0.78) DNMT1DNMT3BDOT1LCARM1EHMT2
SCHEMBL14174718 0.88 DNMT1 (0.78) DNMT1DNMT3BDOT1LCARM1EHMT2
S-Adenosylhomocysteine SCHEMBL12436336 0.86 DOT1L (1.00) DNMT1DNMT3BDOT1LCARM1EHMT2
S-Adenosylhomocysteine SCHEMBL16087786 0.86 DOT1L (1.00) DNMT1DNMT3BDOT1LCARM1EHMT2
S-Adenosylhomocysteine SCHEMBL12378912 0.86 DOT1L (1.00) DNMT1DNMT3BDOT1LCARM1EHMT2
S-Adenosylhomocysteine SCHEMBL14411397 0.86 DOT1L (1.00) DNMT1DNMT3BDOT1LCARM1EHMT2
S-Adenosylhomocysteine SCHEMBL17087726 0.86 DOT1L (1.00) DNMT1DNMT3BDOT1LCARM1EHMT2
S-Adenosylhomocysteine SCHEMBL18296901 0.86 DOT1L (1.00) DNMT1DNMT3BDOT1LCARM1EHMT2
S-Adenosylhomocysteine SCHEMBL21160481 0.86 DOT1L (1.00) DNMT1DNMT3BDOT1LCARM1EHMT2
S-Adenosylhomocysteine SCHEMBL804238 0.86 DOT1L (1.00) DNMT1DNMT3BDOT1LCARM1EHMT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2952182-B1 Compounds and methods for increasing the immune response to papillomavirus UNIV HEIDELBERG (DE) 2022-11-23 — — EP claimed
EP-4536250-A1 CANCER TREATMENT BY ARSENIC TRIOXIDE COMBINATION THERAPY Deutsches Krebsforschungszentrum (DE) 2025-04-16 — — EP disclosed
WO-2023237710-A1 CANCER TREATMENT BY ARSENIC TRIOXIDE COMBINATION THERAPY Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2023-12-14 — — WO disclosed
Send feedback